ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00037635
Recruitment Status : Completed
First Posted : May 20, 2002
Last Update Posted : May 8, 2013
Sponsor:
Information provided by:
Amgen